Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Dropped 6.7% in First Quarter of 2022

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 21.5 million yuan in the first quarter of 2022, down 6.7% year-on-year.

Meanwhile, the company posted 236.9 million yuan in revenue, up 33.5% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 811.4 million yuan in total liabilities, with a liability-to-asset ratio of 33.1%.